Elite in Apolipoprotein C2 Deficiency

Elisabeth Thiessen-Steinhagen

Reinickendorfer Str. 61, 
Berlin, BE, DE 
Elite in Apolipoprotein C2 Deficiency
Reinickendorfer Str. 61, 
Berlin, BE, DE 
OverviewLocationsClinical Research

Overview

Elisabeth Thiessen-Steinhagen practices in Berlin, Germany. Ms. Thiessen-Steinhagen is rated as an Elite expert by MediFind in the treatment of Apolipoprotein C2 Deficiency. Her top areas of expertise are High Cholesterol, Apolipoprotein C2 Deficiency, Familial Lipoprotein Lipase Deficiency, and Familial Hypercholesterolemia.

Her clinical research consists of co-authoring 242 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 5 articles in the study of Apolipoprotein C2 Deficiency.

Gender
Female

Locations

Reinickendorfer Str. 61, Berlin, BE 13347, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double Blind, Placebo-Controlled, Dose Titration, Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 494372 Administered Subcutaneously to Patients With High Lipoprotein(a)
A Randomized, Double Blind, Placebo-Controlled, Dose Titration, Phase 2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 494372 Administered Subcutaneously to Patients With High Lipoprotein(a)
Enrollment Status: Completed
Publish Date: December 20, 2019
Intervention Type: Drug
Study Phase: Phase 2

242 Total Publications

Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.
Gut microbiota-derived imidazole propionate predicts cardiometabolic risk in patients with coronary artery disease.
Journal: European heart journal
Published: June 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Thiessen-Steinhagen's expertise for a condition
ConditionClose
View All 8 Advanced Conditions
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile